Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PBM Industry Divided On Accepting Risk Under Medicare Rx Benefit Plan

Executive Summary

The PBM industry has not yet reached a consensus on whether PBMs should become risk-bearing entities under a Medicare drug benefit proposal.

You may also be interested in...



PCMA Developing Detailed Medicare Rx Benefit Position Statement

The Pharmaceutical Care Management Association is developing a position statement on how a Medicare prescription drug benefit should be designed.

PCMA Developing Detailed Medicare Rx Benefit Position Statement

The Pharmaceutical Care Management Association is developing a position statement on how a Medicare prescription drug benefit should be designed.

Medicare Rx Formularies Would Cover All Drug Classes Under Thomas Bill

Insurance companies providing drug benefits under the House Republican Medicare plan would have to include all therapeutic classes on their formularies.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036213

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel